• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨外泌体与免疫肿瘤微环境之间的动态相互作用:对乳腺癌进展和治疗策略的影响。

Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Gholghasht Ave, Tabriz, Iran.

Department of Biology, Tabriz Branch, Islamic Azad University, Tabriz, Iran.

出版信息

Breast Cancer Res. 2024 Mar 29;26(1):57. doi: 10.1186/s13058-024-01810-z.

DOI:10.1186/s13058-024-01810-z
PMID:38553754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10981336/
Abstract

Breast cancer continues to pose a substantial worldwide health concern, demanding a thorough comprehension of the complex interaction between cancerous cells and the immune system. Recent studies have shown the significant function of exosomes in facilitating intercellular communication and their participation in the advancement of cancer. Tumor-derived exosomes have been identified as significant regulators in the context of breast cancer, playing a crucial role in modulating immune cell activity and contributing to the advancement of the illness. This study aims to investigate the many effects of tumor-derived exosomes on immune cells in the setting of breast cancer. Specifically, we will examine their role in influencing immune cell polarization, facilitating immunological evasion, and modifying the tumor microenvironment. Furthermore, we explore the nascent domain of exosomes produced from immune cells and their prospective involvement in the prevention of breast cancer. This paper focuses on new research that emphasizes the immunomodulatory characteristics of exosomes produced from immune cells. It also explores the possibility of these exosomes as therapeutic agents or biomarkers for the early identification and prevention of breast cancer. The exploration of the reciprocal connections between exosomes formed from tumors and immune cells, together with the rising significance of exosomes derived from immune cells, presents a potential avenue for the advancement of novel approaches in the field of breast cancer therapy and prevention.

摘要

乳腺癌仍然是一个全球性的重大健康问题,需要深入理解癌细胞和免疫系统之间的复杂相互作用。最近的研究表明,外泌体在促进细胞间通讯方面具有重要功能,并且它们参与了癌症的进展。肿瘤衍生的外泌体已被确定为乳腺癌背景下的重要调节因子,在外泌体在调节免疫细胞活性和促进疾病进展方面起着至关重要的作用。本研究旨在探讨肿瘤衍生的外泌体在乳腺癌中对免疫细胞的多种影响。具体来说,我们将研究它们在影响免疫细胞极化、促进免疫逃逸以及改变肿瘤微环境方面的作用。此外,我们还探讨了免疫细胞产生的外泌体的新兴领域及其在预防乳腺癌方面的潜在作用。本文重点介绍了强调免疫细胞来源的外泌体免疫调节特性的新研究。它还探讨了这些外泌体作为治疗剂或生物标志物用于早期识别和预防乳腺癌的可能性。探索肿瘤和免疫细胞来源的外泌体之间的相互联系,以及免疫细胞来源的外泌体的重要性日益增加,为乳腺癌治疗和预防领域的新方法的发展提供了潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/20fd91c3e100/13058_2024_1810_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/9f6062a2fdb4/13058_2024_1810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/d6755a45f0b9/13058_2024_1810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/b6a1a67bbb9a/13058_2024_1810_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/6d0e8cf2836f/13058_2024_1810_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/0aa5d44a60c6/13058_2024_1810_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/20fd91c3e100/13058_2024_1810_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/9f6062a2fdb4/13058_2024_1810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/d6755a45f0b9/13058_2024_1810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/b6a1a67bbb9a/13058_2024_1810_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/6d0e8cf2836f/13058_2024_1810_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/0aa5d44a60c6/13058_2024_1810_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fce/10981336/20fd91c3e100/13058_2024_1810_Fig6_HTML.jpg

相似文献

1
Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies.探讨外泌体与免疫肿瘤微环境之间的动态相互作用:对乳腺癌进展和治疗策略的影响。
Breast Cancer Res. 2024 Mar 29;26(1):57. doi: 10.1186/s13058-024-01810-z.
2
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
3
Exosome-mediated crosstalk between tumor cells and innate immune cells: implications for cancer progression and therapeutic strategies.外泌体介导的肿瘤细胞与固有免疫细胞间串扰:对癌症进展和治疗策略的启示。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9487-9503. doi: 10.1007/s00432-023-04833-9. Epub 2023 May 8.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Dissecting Exosomal-Tumoral-Vascular Interactions of Single Tumor Cells and Clusters Using a Tumoral-Transendothelial Migration Chip.使用肿瘤跨内皮迁移芯片剖析单个肿瘤细胞和肿瘤细胞簇的外泌体-肿瘤-血管相互作用
ACS Nano. 2025 Jul 8;19(26):23680-23692. doi: 10.1021/acsnano.5c02557. Epub 2025 Jun 24.
6
Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment.乳腺癌外泌体:调控肿瘤微环境中的巨噬细胞极化与免疫调节
Semin Oncol. 2025 Jun 19;52(4):152365. doi: 10.1016/j.seminoncol.2025.152365.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
The Role of Immunotherapy and Immune Modulators in Hormone-Positive Breast Cancer: Implications for Localized and Metastatic Disease.免疫疗法和免疫调节剂在激素阳性乳腺癌中的作用:对局部和转移性疾病的影响
J Clin Med. 2025 Jun 17;14(12):4322. doi: 10.3390/jcm14124322.
9
Exosomes: a potential tool in the diagnosis, prognosis and treatment of patients with colorectal cancer.外泌体:结直肠癌患者诊断、预后及治疗的潜在工具。
Future Oncol. 2025 Aug;21(18):2347-2365. doi: 10.1080/14796694.2025.2520150. Epub 2025 Jun 14.
10
Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance.真菌与癌症:揭示真菌感染在肿瘤生物学和治疗耐药性中的复杂作用
Front Cell Infect Microbiol. 2025 Jun 10;15:1596688. doi: 10.3389/fcimb.2025.1596688. eCollection 2025.

引用本文的文献

1
Extracellular vesicles in intestinal protozoa: hidden mediators of host-parasite communication.肠道原生动物中的细胞外囊泡:宿主-寄生虫通讯的隐藏介质
Gut Pathog. 2025 Aug 28;17(1):69. doi: 10.1186/s13099-025-00747-8.
2
JMJD8 overexpression in breast cancer: implications for diagnosis, prognosis, and immune microenvironment interactions.JMJD8在乳腺癌中的过表达:对诊断、预后及免疫微环境相互作用的影响
Front Oncol. 2025 Jul 21;15:1536278. doi: 10.3389/fonc.2025.1536278. eCollection 2025.
3
Unveiling the power of exosomal non-coding RNAs: key drivers of lung cancer progression in the tumor microenvironment.

本文引用的文献

1
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications.免疫细胞衍生的外泌体修饰增强癌症免疫治疗:当前进展和治疗应用。
Exp Mol Med. 2024 Feb;56(1):19-31. doi: 10.1038/s12276-023-01132-8. Epub 2024 Jan 4.
2
New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.微小RNA在乳腺癌脑转移中的分子机制新见解及治疗靶点
Noncoding RNA Res. 2023 Sep 28;8(4):645-660. doi: 10.1016/j.ncrna.2023.09.003. eCollection 2023 Dec.
3
Tumor-derived exosomes RNA expression profiling identifies the prognosis, immune characteristics, and treatment in HR+/HER2-breast cancer.
揭示外泌体非编码RNA的力量:肿瘤微环境中肺癌进展的关键驱动因素
Med Oncol. 2025 Jul 1;42(8):308. doi: 10.1007/s12032-025-02791-5.
4
The Design of a Multistage Monitoring Protocol for Dendritic Cell-Derived Exosome (DEX) Immunotherapy: A Conceptual Framework for Molecular Quality Control and Immune Profiling.树突状细胞衍生外泌体(DEX)免疫疗法的多阶段监测方案设计:分子质量控制和免疫分析的概念框架
Int J Mol Sci. 2025 Jun 6;26(12):5444. doi: 10.3390/ijms26125444.
5
Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer.自然杀伤细胞衍生的外泌体:改变侵袭性乳腺癌的免疫疗法。
Med Oncol. 2025 Mar 18;42(4):114. doi: 10.1007/s12032-025-02647-y.
6
Advancements in Exosome Proteins for Breast Cancer Diagnosis and Detection: With a Focus on Nanotechnology.外泌体蛋白在乳腺癌诊断和检测中的进展:聚焦纳米技术。
AAPS PharmSciTech. 2024 Nov 27;25(8):276. doi: 10.1208/s12249-024-02983-8.
7
Exosomal ncRNAs in reproductive cancers†.生殖系统癌症中的外泌体非编码RNA†
Biol Reprod. 2025 Feb 14;112(2):225-244. doi: 10.1093/biolre/ioae170.
8
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.外泌体与癌症干细胞(CSCs)的治疗组合以及癌症治疗中癌症干细胞衍生外泌体(CSCEXs)的治疗组合。
Cancer Cell Int. 2024 Oct 5;24(1):334. doi: 10.1186/s12935-024-03514-y.
9
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities.乳腺癌中的细胞外囊泡:从细胞间通讯到治疗机遇
Pharmaceutics. 2024 May 14;16(5):654. doi: 10.3390/pharmaceutics16050654.
10
Nanoscale strides: exploring innovative therapies for breast cancer treatment.纳米尺度的进展:探索乳腺癌治疗的创新疗法。
RSC Adv. 2024 Apr 29;14(20):14017-14040. doi: 10.1039/d4ra02639j. eCollection 2024 Apr 25.
肿瘤来源的外泌体 RNA 表达谱分析鉴定 HR+/HER2-乳腺癌的预后、免疫特征和治疗。
Aging (Albany NY). 2023 Aug 29;15(16):8471-8486. doi: 10.18632/aging.204986.
4
Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.自然杀伤细胞衍生的外泌体介导索拉非尼递呈增强三阴性乳腺癌细胞凋亡
Nanomedicine (Lond). 2023 Feb;18(5):437-453. doi: 10.2217/nnm-2022-0237. Epub 2023 May 18.
5
Exosomes: Insights and therapeutic applications in cancer.外泌体:癌症研究的新见解与治疗应用
Transl Oncol. 2022 Jul;21:101439. doi: 10.1016/j.tranon.2022.101439. Epub 2022 May 9.
6
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application.外泌体作为乳腺癌新兴的药物递送和诊断方式:分离与应用的最新进展
Cancers (Basel). 2022 Mar 10;14(6):1435. doi: 10.3390/cancers14061435.
7
Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.外泌体 MMP-1 通过 PAR1 介导的 EMT 转移三阴性乳腺癌的转移潜能。
Breast Cancer Res Treat. 2022 May;193(1):65-81. doi: 10.1007/s10549-022-06514-6. Epub 2022 Mar 7.
8
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.工程化外泌体作为原位 DC 致敏疫苗增强乳腺癌的抗肿瘤免疫。
Mol Cancer. 2022 Feb 11;21(1):45. doi: 10.1186/s12943-022-01515-x.
9
Recent advances in targeted nanotherapeutic approaches for breast cancer management.靶向纳米治疗方法在乳腺癌管理中的最新进展。
Nanomedicine (Lond). 2021 Dec;16(29):2605-2631. doi: 10.2217/nnm-2021-0281. Epub 2021 Dec 2.
10
Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7.癌相关成纤维细胞衍生的外泌体 miR-18b 通过调控 TCEAL7 促进乳腺癌侵袭和转移。
Cell Death Dis. 2021 Dec 1;12(12):1120. doi: 10.1038/s41419-021-04409-w.